Using cell-specific late-phase asthma mRNA biomarkers to repurpose drugs that concurrently reverse disease signatures across multiple immune cell-types.
Saved in:
| Title: | Using cell-specific late-phase asthma mRNA biomarkers to repurpose drugs that concurrently reverse disease signatures across multiple immune cell-types. |
|---|---|
| Authors: | Zhang, Mingming1,2,3 (AUTHOR), Kim, Young Woong1,2,3 (AUTHOR), Yang, Chen Xi2 (AUTHOR), Gauvreau, Gail M.4 (AUTHOR), FitzGerald, J. Mark5 (AUTHOR), Boulet, Louis-Philippe6 (AUTHOR), O'Byrne, Paul M.4 (AUTHOR), Tebbutt, Scott J.2,3,5,7 (AUTHOR), Singh, Amrit1,2,3 (AUTHOR) amrit.singh@ubc.ca |
| Source: | PLoS Computational Biology. 4/3/2026, Vol. 22 Issue 4, p1-19. 19p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 1553734X |
|---|---|
| DOI: | 10.1371/journal.pcbi.1014081 |
